# ADAPTIVE ASSURANCE AQ14 — Final ADAPT-QA Effectiveness Qualification

AQ14 is the terminal registered phase of the current ADAPT-QA campaign. It performs a deterministic `EVIDENCE_ONLY_NON_AUTHORIZING` qualification of the already-canonical AQ9 through AQ13 evidence chain. AQ14 does not deploy Orchestra, change routing, activate a provider, alter protected policy, admit CritiQual CUD10, or create lifecycle authority.

## Boundary

AQ14 starts from canonical Orchestra AQ13 `34eb2a38a97f6d1acef6bbd206da8795393457de` and runs only in `CONTROLLED_NON_PRODUCTION_FINAL_EFFECTIVENESS_QUALIFICATION` mode.

The qualification consumes exactly five canonical phases in order:

1. `AQ9` — deep deterministic assurance
2. `AQ10` — defect-escape RCA
3. `AQ11` — controlled remediation/effectiveness pilot
4. `AQ12` — Orchestra adversarial self-test
5. `AQ13` — staged non-production rollout evaluation

Each row is pinned to its exact canonical PR, SHA, and tree. Substituted or reordered evidence is rejected rather than silently normalized.

## Qualification requirements

For every required phase, AQ14 requires:

- exact canonical identity;
- a `PASS` phase disposition;
- canonical verification;
- source-assurance success;
- promotion-assurance success;
- post-merge-assurance success;
- independent evidence;
- deterministic evidence; and
- zero unresolved critical findings.

A prior `REVISION_REQUIRED` or `HOLD`, or any unresolved critical finding, forces AQ14 `REVISION_REQUIRED`. Missing, non-independent, non-deterministic, or incomplete assurance evidence produces `WAIT_FOR_EVIDENCE`. Only the complete exact evidence chain can produce `PASS`.

## Claim scope

AQ14 `PASS` means only that the controlled canonical AQ9–AQ13 evidence chain satisfies the registered ADAPT-QA final qualification contract. It does **not** establish an unrestricted organic-effectiveness claim and it is not a production-readiness or production-readiness-equivalent claim.

The qualification therefore distinguishes:

```text
CONTROLLED EVIDENCE CHAIN QUALIFIED
        !=
ORGANIC PRODUCTION EFFECTIVENESS PROVEN
        !=
PRODUCTION DEPLOYMENT AUTHORIZED
```

## Prime Directive alignment

Under the Prime Directive, a failing AQ14 result may be remediated only by repairing truthful evidence or implementation defects while preserving the exact human-approved inventory and existing assurance thresholds. The run may not obtain PASS by deleting a phase, substituting canonical identities, ignoring a HOLD or critical finding, weakening evidence independence, lowering assurance requirements, or expanding protected policy.

If a legitimate remediation would require a path outside the exact AQ14 inventory, AQ14 freezes for human governance review.

## Authority boundary

AQ14 preserves all existing controls:

- Arbiter remains lifecycle-transition owner.
- The human-owned ADAPT-QA phase registry remains protected policy.
- Whitelist mutation remains human-only.
- Provider and telemetry activation remain unauthorized.
- Production mutation and release/deployment remain unauthorized.
- CritiQual `CUD10` remains `READY_NOT_STARTED_HELD_BY_CURRENT_USER`.
- AQ14 `PASS` does not authorize AQ15 or any later unregistered phase.
- AQ14 `PASS` grants no transition, release, production, provider, whitelist, protected-policy, or CUD10 admission authority.

AQ14 completes the currently registered AQ9–AQ14 development-assurance campaign. Any AQ15+ work requires a fresh human governance decision.
